Abiopharma

🔍 ARNOLD FRANCES (Executive)

Company: Generate Biomedicines, Inc. (GENB)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Sold 1,000 shares of Common Stock at $16.002 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: false | shares_owned_after: 231,472.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-09-01 | Code: H | nature_of_ownership: By The Frances Arnold 2010 Irrevocable Trust | shares_owned_after: 232,472.00 | Footnotes: F3

Footnotes:

• F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
• F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.00 to $16.01 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of her pecuniary interest therein, if any. This report shall not be deemed an admission that she is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.